Romania · Delayed Price · Currency is RON Med Life Statistics
Total Valuation
Med Life has a market cap or net worth of RON 6.50 billion. The enterprise value is 8.37 billion.
| Market Cap | 6.50B |
| Enterprise Value | 8.37B |
Important Dates
The next confirmed earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Med Life has 530.82 million shares outstanding. The number of shares has decreased by -0.02% in one year.
| Current Share Class | 530.82M |
| Shares Outstanding | 530.82M |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 36.47% |
| Owned by Institutions (%) | 38.13% |
| Float | 337.25M |
Valuation Ratios
The trailing PE ratio is 846.84 and the forward PE ratio is 76.50.
| PE Ratio | 846.84 |
| Forward PE | 76.50 |
| PS Ratio | 2.00 |
| PB Ratio | 11.44 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 435.61 |
| P/OCF Ratio | 32.09 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.45, with an EV/FCF ratio of 561.41.
| EV / Earnings | 1,091.39 |
| EV / Sales | 2.58 |
| EV / EBITDA | 18.45 |
| EV / EBIT | 52.38 |
| EV / FCF | 561.41 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 3.47.
| Current Ratio | 0.80 |
| Quick Ratio | 0.55 |
| Debt / Equity | 3.47 |
| Debt / EBITDA | 4.34 |
| Debt / FCF | 132.16 |
| Interest Coverage | 1.70 |
Financial Efficiency
Return on equity (ROE) is -1.04% and return on invested capital (ROIC) is -2.20%.
| Return on Equity (ROE) | -1.04% |
| Return on Assets (ROA) | 3.11% |
| Return on Invested Capital (ROIC) | -2.20% |
| Return on Capital Employed (ROCE) | 6.64% |
| Weighted Average Cost of Capital (WACC) | 4.64% |
| Revenue Per Employee | 481,838 |
| Profits Per Employee | 1,138 |
| Employee Count | 6,962 |
| Asset Turnover | 1.01 |
| Inventory Turnover | 10.86 |
Taxes
In the past 12 months, Med Life has paid 23.16 million in taxes.
| Income Tax | 23.16M |
| Effective Tax Rate | 132.22% |
Stock Price Statistics
The stock price has increased by +75.61% in the last 52 weeks. The beta is 0.41, so Med Life's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +75.61% |
| 50-Day Moving Average | 11.75 |
| 200-Day Moving Average | 11.02 |
| Relative Strength Index (RSI) | 55.01 |
| Average Volume (20 Days) | 326,381 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Med Life had revenue of RON 3.25 billion and earned 7.67 million in profits. Earnings per share was 0.01.
| Revenue | 3.25B |
| Gross Profit | 1.58B |
| Operating Income | 159.86M |
| Pretax Income | 17.52M |
| Net Income | 7.67M |
| EBITDA | 351.30M |
| EBIT | 159.86M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 168.41 million in cash and 1.97 billion in debt, with a net cash position of -1.80 billion or -3.40 per share.
| Cash & Cash Equivalents | 168.41M |
| Total Debt | 1.97B |
| Net Cash | -1.80B |
| Net Cash Per Share | -3.40 |
| Equity (Book Value) | 568.00M |
| Book Value Per Share | 0.93 |
| Working Capital | -187.12M |
Cash Flow
In the last 12 months, operating cash flow was 202.47 million and capital expenditures -187.56 million, giving a free cash flow of 14.92 million.
| Operating Cash Flow | 202.47M |
| Capital Expenditures | -187.56M |
| Depreciation & Amortization | 191.44M |
| Net Borrowing | 56.44M |
| Free Cash Flow | 14.92M |
| FCF Per Share | 0.03 |
Margins
Gross margin is 48.48%, with operating and profit margins of 4.92% and 0.24%.
| Gross Margin | 48.48% |
| Operating Margin | 4.92% |
| Pretax Margin | 0.54% |
| Profit Margin | 0.24% |
| EBITDA Margin | 10.81% |
| EBIT Margin | 4.92% |
| FCF Margin | 0.46% |
Dividends & Yields
Med Life does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.02% |
| Shareholder Yield | 0.02% |
| Earnings Yield | 0.12% |
| FCF Yield | 0.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Med Life is 10.23, which is -16.15% lower than the current price. The consensus rating is "Hold".
| Price Target | 10.23 |
| Price Target Difference | -16.15% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 10.41% |
| EPS Growth Forecast (3Y) | 214.98% |
Stock Splits
The last stock split was on September 1, 2023. It was a forward split with a ratio of 4.
| Last Split Date | Sep 1, 2023 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Med Life has an Altman Z-Score of 2.1 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.1 |
| Piotroski F-Score | 6 |